{"count": 1, "results": [{"_id": "12187114", "pmid": 12187114, "title": "Recovery from hemodialysis therapy in a patient with renal cholesterol crystal embolism.", "journal": "Nephron", "authors": ["Kato A", "Ohtsuji A", "Terada T", "Goto T", "Fukasawa H", "Yasuda H", "Togawa A", "Fujimoto T", "Suzuki H", "Fujigaki Y", "Yamamoto T", "Yonemura K", "Hishida A"], "date": "2002-09-01T00:00:00Z", "doi": "10.1159/000064457", "meta_date_publication": "2002 Sep", "meta_volume": "92", "meta_issue": "1", "meta_pages": "240-3", "score": 50045.535, "text_hl": "His serum @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@ level increased from 2.18 to 8.57 mg/dl over 6 weeks, and HD treatment was started. Treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (5 mg/day) did not reverse @DISEASE_Renal_Insufficiency @DISEASE_MESH:D051437 @@@renal failure@@@ and @DISEASE_Eosinophilia @DISEASE_MESH:D004802 @@@hypereosinophilia@@@, but the @<m>DISEASE_Amputation_Congenital</m> @DISEASE_MESH:C565682 @@@amputation of@@@ right @DISEASE_Gangrene @DISEASE_MESH:D005734 @@@gangrene@@@ toes promptly increased urine output and @DISEASE_Eosinophilia @DISEASE_MESH:D004802 @@@eosinophilia@@@ completely disappeared concomitantly with a decline of @GENE_CRP @GENE_1401 @@@C-reactive protein@@@ from 9.7 to 0.7 mg/dl. ", "citations": {"NLM": "Kato A, Ohtsuji A, Terada T, Goto T, Fukasawa H, Yasuda H, Togawa A, Fujimoto T, Suzuki H, Fujigaki Y, Yamamoto T, Yonemura K, Hishida A. Recovery from hemodialysis therapy in a patient with renal cholesterol crystal embolism. Nephron. 2002 Sep;92(1):240-3. PMID: 12187114", "BibTeX": "@article{12187114, title={Recovery from hemodialysis therapy in a patient with renal cholesterol crystal embolism.}, author={Kato A and Ohtsuji A and Terada T and Goto T and Fukasawa H and Yasuda H and Togawa A and Fujimoto T and Suzuki H and Fujigaki Y and Yamamoto T and Yonemura K and Hishida A}, journal={Nephron}, volume={92}, number={1}, pages={240-3}}"}}]}